| 產(chǎn)品描述： | Thymalfasin is an immunomodulating agent able to enhance the Thl immune response. |
| 靶點： |
Peptides |
| 體內(nèi)研究： |
Thymalfasin has been shown to have efficacy in multiple experimental models of immune dysfunction, mainly, infectious diseases such as hepatitis (woodchuck) and influenza (mouse), and cancer such as melanoma (mouse) and colorectal carcinoma (rat) where thymalfasin has shown antitumor effects |
| 參考文獻： |
1. Lao X et al. A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects. Apoptosis. 2015 Oct;20(10):1307-20. 2. Sjogren MH et al. Thymalfasin: an immune system enhancer for the treatment of liver disease. J Gastroenterol Hepatol. 2004 Dec;19(12):S69-72. |
| 溶解性： |
H2O : 0.3 mg/mL (0.10 mM; Need ultrasonic and warming) |
| 保存條件： |
-20℃ |
| 配置溶液濃度參考： |
|
1mg |
5mg |
10mg |
| 1 mM |
0.322 ml |
1.609 ml |
3.217 ml |
| 5 mM |
0.064 ml |
0.322 ml |
0.643 ml |
| 10 mM |
0.032 ml |
0.161 ml |
0.322 ml |
| 50 mM |
0.006 ml |
0.032 ml |
0.064 ml |
|
| 注意： |
部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權威性，僅供客戶參考交流研究之用。 |
上海工商
危險品化學品經(jīng)營許可證（不帶存儲）
營業(yè)執(zhí)照(三證合一)
北京